Sarcoma, Myeloid
Showing 26 - 50 of 3,609
Extramedullary Acute Myeloid Leukemia: Retrospective Single
Completed
- Acute Myeloid Leukemia
- retrospective data analysis
-
Amman, JordanKing Hussein Cancer Center
Sep 15, 2021
Central Nervous System Involvement in Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia
- Observation of CNS involvement
-
Alessandria, Italy
- +13 more
Dec 31, 2021
Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)
Completed
- Pancreas Cancer
- +6 more
-
Rozzano, Milan, ItalyIstituto Clinico Humanitas
Sep 9, 2022
Precision Medicine for Every Child With Cancer
Recruiting
- Childhood Cancer
- +5 more
- Whole Genome Sequencing
- +6 more
-
Adelaide, Australia
- +8 more
Jan 24, 2023
Histiocytic Disorder Follow-up Study
Recruiting
- Histiocytosis
- +5 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 13, 2023
CAR, Acute Myeloid Leukemia Trial in Hefei (Chimeric antigen receptor T cells (car-t))
Recruiting
- CAR
- Acute Myeloid Leukemia
- Chimeric antigen receptor T cells (car-t)
-
Hefei, Anhui, ChinaAnhui Provincial Hospital
Mar 4, 2021
Solid Tumor Trial in United States (drug, combination product, biological)
Recruiting
- Solid Tumor
- Pembrolizumab
- +2 more
-
Sacramento, California
- +6 more
Jan 3, 2023
Acute Myeloid Leukemia (AML) Trial in Worldwide (Placebo, Venetoclax, Cytarabine)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Placebo
- +2 more
-
Tampa, Florida
- +108 more
Jul 15, 2022
Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)
Active, not recruiting
- Sarcoma, Soft Tissue
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Oct 29, 2023
Leukemia, Acute Myeloid (AML) Trial in Worldwide (gilteritinib, LoDAC (Low Dose Cytarabine), Azacitidine)
Active, not recruiting
- Leukemia, Acute Myeloid (AML)
- gilteritinib
- +4 more
-
Birmingham, Alabama
- +125 more
Aug 9, 2022
Metastatic Sarcoma, Sarcoma Trial in Seattle (Assessment, Questionnaire Administration, Interview)
Not yet recruiting
- Metastatic Sarcoma
- Sarcoma
- Assessment
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Apr 27, 2023
Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)
Completed
- Objective Response
- Overall Survival
- VIA combination treatment
-
Beijing, ChinaPeking University People's Hospital
Dec 9, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Sarcoma Trial in Columbus (Educational Intervention, Quality-of-Life Assessment, Survey Administration)
Completed
- Sarcoma
- Educational Intervention
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 26, 2022
Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )
Active, not recruiting
- Alveolar Soft Part Sarcoma
- +3 more
- AL3818
- +2 more
-
Phoenix, Arizona
- +22 more
Nov 1, 2022
Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)
Recruiting
- Liver Metastases
- +10 more
- DNX-2440
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute, Inc.
Mar 28, 2022
Soft Tissue Sarcoma Trial (Cadonilimab)
Not yet recruiting
- Soft Tissue Sarcoma
- Cadonilimab
- (no location specified)
Dec 9, 2022
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)
Recruiting
- Ewing Sarcoma
- +6 more
- FoundationOne Liquid CDx
-
Los Angeles, California
- +14 more
Oct 5, 2023
Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors Trial in France (Sampling on blood, bone marrow and
Recruiting
- Neuroblastoma
- +5 more
- Sampling on blood, bone marrow and cerebrospinal fluid
-
Amiens, France
- +29 more
Feb 23, 2022
Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)
Recruiting
- Advanced Sarcoma
- +2 more
- YH001
- +2 more
-
Santa Monica, CaliforniaSarcoma Oncology Center
Dec 5, 2022
Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)
Recruiting
- Ewing Sarcoma
- Ewing-Like Sarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022
Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)
Recruiting
- Soft Tissue Sarcoma
- Fluzoparib
- Preoperative moderately fractionated radiotherapay
-
Beijing, Beijing, China
- +1 more
Jul 3, 2023